Continuous administration of the p38α inhibitor neflamapimod during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level
J. J. Alam, M. Krakovsky, U. Germann, A. Levy
This study shows that neflamapimod, a p38 inhibitor, improves functional recovery and increases BDNF levels in rats after stroke when administered during the subacute phase.
bioRxiv · Apr 29, 2020Pharmacology & Toxicology